Agenus (AGEN) vs SL Science (SLBT)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
Agenus (AGEN) has outperformed SL Science (SLBT) over the past year, gaining 41.5% versus a loss of 94.8%. SL Science is the larger company by market cap ($308.4 million vs $270.1 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | AGEN | SLBT |
|---|---|---|
| Share price | $5.97 | $0.55 |
| Market cap | $270.12M | $308.42M |
| 1-day change | -2.77% | -3.36% |
| YTD return | +90.13% | -94.78% |
| 1-year return | +41.47% | -94.76% |
| 5-year return | -90.58% | — |
| P/E ratio (TTM) | 25.96 | — |
| EPS (TTM) | $0.23 | $0.00 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | $114.20M | — |
| Revenue growth (YoY) | +10.37% | — |
| Net income (latest FY) | $-3.08M | — |
| Gross margin | 99.11% | — |
| Operating margin | -17.66% | — |
| Net margin | -2.70% | — |
| 52-week high | $10.31 | $14.50 |
| 52-week low | $2.71 | $0.51 |
| Distance from 52-week high | -42.10% | -96.21% |
| Analyst consensus | strong_buy | — |
| Avg. price target upside | +352.26% | — |
| Average volume | 905.17K | 67.66K |
| Shares outstanding | 45.25M | 560.76M |
| Employees | 81 | 14 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Biotechnology: Biological Products (No Diagnostic Substances) |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- AGEN has outperformed SLBT by 136.2 percentage points over the past year.
About Agenus
AGEN stock →Agenus Inc., a clinical-stage biotechnology company, discovers and develops immunotherapies for cancer and infectious diseases in the United States and internationally. It offers Retrocyte Display, an antibody expression platform for the identification of fully human and humanized monoclonal antibodies; and display technologies.
Health Care · Biotechnology: Biological Products (No Diagnostic Substances) · 81 employees
About SL Science
SLBT stock →SL Science Holding Limited manufactures cosmetic skin care and scalp care products. The company's products include SL bio's milk-derived exosome essence, SL bio's tangerine-derived extract, and the MilkExo concentrate series.
Health Care · Biotechnology: Biological Products (No Diagnostic Substances) · 14 employees
AGEN vs SLBT FAQ
Which is bigger, Agenus or SL Science?
SL Science (SLBT) is larger, with a market capitalization of $308.42M compared with $270.12M for Agenus (AGEN).
Which stock has performed better over the past year, AGEN or SLBT?
AGEN returned +41.47% over the past 12 months, compared with -94.76% for SLBT (price return, excluding dividends). Past performance does not predict future results.
Are Agenus and SL Science in the same industry?
Yes. Both are classified in the Biotechnology: Biological Products (No Diagnostic Substances) industry within the Health Care sector.